Answers go deeper than the script: questioning keeps surfacing new concrete detail behind a positive development · compa
The model's full reasoning — Q2 2017 call → NOWe need answer only YES or NO. Need evaluate both gates. Need use transcript. We need identify positive current development management highlights and analysts probe, with additive detail. Also engine internal vs external. Let's parse transcript. Company Olin, Q2 2017. Prepared remarks: adjusted EBITDA missed due to VCM turnaround and epoxy outage, Winchester weak. But positive: Chlor Alkali products strong, caustic soda prices up, chlorine prices, EDC, bleach. Also ethylene second tranche expected in Q3. Epoxy expected improve. They reaffirm $1B EBITDA. Q&A topics: - EDC pricing outlook: Jim Varilek explains lower forecast due to incremental players coming on with EDC to get caustic. This is not positive current development? It's about pricing, external. - Caustic soda price realizations: management says July indices, expectations. Not additive? They say second quarter realized doesn't reflect second quarter indices, still to come. That's about pricing. - EDC exposure, contracts. - Caustic sequential increase. - EDC impact Formosa force majeure. - Ethylene contract with Dow: question about timing, management says expect receive second tranche in Q3, full-year outlook reflects. Not much detail. - Winchester long-term $125M: John says yes, worst behind, run rate second half supports. No specifics. - Caustic price guidance: John says guidance reflects $30 increase, further increase upside. Not additive. - Contract renewals: Jim says success removing discounts, contracts 2-5 years. Some detail but not concrete numbers. - Guidance tracking: John says biggest difference unplanned outages $45-50M. Not positive. - Caustic export issues: John says export prices year-over-year up more than domestic, near parity. Some detail. - Winchester confidence: John says customers selling more than buying not sustainable, Q3 seasonal, military benefit second half. General. - Synergies: no change, bleach growth 15%. - Caustic volumes vs chlorine: John explains merchant chlorine unaffected, outages affected internal. This is about weakness. - Epoxy volume growth: Pat says upstream and Europe. Some detail. - Chlorine price: flat sequential, up 5% y/y. - Epoxy profitability second half: John says return to Q3 last year margins. Projection. - Epoxy pricing sustainability: Pat says demand modest improvements, Europe grows, Asia bottom. General. - Caustic volume decline: no comment.
The model's full reasoning — Q2 2018 call → NOWe need answer only YES or NO. Need evaluate both gates. We need parse transcript. Need determine Gate1: positive current development with Q&A adding more concrete operating detail than prepared remarks. Gate2: engine is company-created vs external. Let's identify main positive developments: Chlor Alkali strong, caustic soda pricing, EDC prices, Epoxy improvement, Winchester? The call highlights Chlor Alkali and Epoxy. Q&A probes caustic soda, EDC, epoxy, Winchester, etc. Gate1: Need see if Q&A adds concrete operating detail about a positive current development. Examples: caustic soda pricing, contract renewals, demand. Prepared remarks already detailed. Q&A: Jim Varilek gives some specifics about demand, contract momentum, capacity additions, trade flows. But is it additive? Let's examine. Question about caustic soda contracts: "If all contract caustic now priced at market, would that make difference?" Jim says contracts renew over 2-3 years, momentum into Q3, index changes. John adds contract renewal season Q4, contracts 3-5 years, some negotiated 2015, expect meaningful improvement in netback Q1 2019 vs Q4. This is additive? It gives detail about contract structure and timing, but not necessarily "development" operations? It is about pricing mechanism, not actual operations? It is current development: caustic soda price increases. Q&A adds specifics about contract renewals and timing. But is it "more concrete operating detail than prepared remarks"? Prepared remarks said domestic caustic prices increased 5% Q2, expect further Q3, export weakness, long-term positive. Q&A adds contract renewal timing, netback improvement. That is substantive? It concerns pricing economics, not volumes/customers. Could be considered financial/price mechanics. But Gate1 asks "concrete operating detail" such as customers, volumes, timing, capacity, economics. Contract renewal timing is economics. But is it "development" going well? Yes caustic pricing. Another positive: EDC prices increased 40% Q2, expect further Q3. Q&A: question about EDC and caustic relationship. John explains EDC entirely export, domestic caustic vs export caustic. Not much new. Epoxy: Q&A asks about operating rates, price increases, raw material costs. Pat says supply/demand improving, China environmental enforcement, no new capacity, growth 3-5%. But no specific numbers.
The model's full reasoning — Q1 2016 call → NOWe need answer only YES or NO. Need evaluate both gates. Need use transcript. Gate 1: positive current development with Q&A adding more concrete operating detail than prepared remarks. Need identify development. In call, positive developments: synergies, caustic soda pricing improvements, Epoxy volume growth, Winchester improvements, bleach capacity. Q&A probes caustic soda pricing, Epoxy, HCl, etc. Need see if Q&A adds concrete specifics beyond prepared remarks. Prepared remarks already detailed caustic pricing, April index up $17, announced increases, etc. Q&A: Jim Varilek announces three price increases totaling $85/ton ($30 April, $25 May, $30 June) - that's new specific detail not in prepared remarks? Prepared remarks said April domestic contract caustic soda price indices increased $17 per ton, reflected in guidance. Q&A adds announced increases for May/June, total $85. Also Q&A adds caustic export percentage 8-10% of third-party sales. Also Q&A adds chlorine index up $20 in April. Also Q&A adds HCl supply dynamics. Also Q&A adds Epoxy capacity utilization not reported, but Europe growth rates 3.5-4.5%, US 1-2%. Also Q&A adds stock comp sensitivity. Need determine if there is a positive current development that Q&A adds more concrete operating detail. The main positive development probed is caustic soda pricing improvement. Prepared remarks: "April domestic contract caustic soda price indices increased $17 per ton... reflected in guidance." Q&A: "We've announced three price increases for the quarter totaling $85 a ton. We've gone $30 a ton in April, $25 a ton in May, and $30 a ton for June." That is additive, specific, current (announced). Also Q&A: "The index is up in April $20 a ton" for chlorine. Also Q&A: "We do have exports... 8% to 10% of third-party sales." That's new. Also Q&A: "We've already had some sequential improvement in the month of April. We're now into May, but very early in May." That's current. So Gate 1 likely YES. Gate 2: Improvement filter. Main positive development: caustic soda pricing improvement. Is engine company-created or external? Caustic soda pricing improvement driven by external market factors: supply reductions in Europe, China demand, exports to Australia, industry capacity reductions. Management highlights macro factors.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MNDY | monday.com Ltd. | Q4 2024 | 2024-05-15 | A |
| ZLAB | Zai Lab Limited | Q1 2024 | 2024-05-09 | B |
| YOU | Clear Secure, Inc. | Q1 2024 | 2024-05-08 | C+ |
| STIM | Neuronetics, Inc. | Q1 2024 | 2024-05-07 | B |
| CMG | Chipotle Mexican Grill, Inc. | Q1 2024 | 2024-04-24 | A |
| CSGP | CoStar Group, Inc. | Q1 2024 | 2024-04-23 | B+ |
| SAP | SAP SE | Q1 2024 | 2024-04-22 | B |
| AREC | American Resources Corporation | Q4 2023 | 2024-03-28 | F |
| QRHC | Quest Resource Holding Corporation | Q4 2023 | 2024-03-12 | C+ |
| ALKT | Alkami Technology, Inc. | Q4 2023 | 2024-03-02 | A |
| MCW | Mister Car Wash, Inc. | Q4 2023 | 2024-02-21 | D |
| TYL | Tyler Technologies, Inc. | Q4 2023 | 2024-02-15 | C+ |
| GDDY | GoDaddy Inc. | Q4 2023 | 2024-02-13 | B+ |
| SYY | Sysco Corporation | Q2 2024 | 2024-01-30 | B+ |
| STLD | Steel Dynamics, Inc. | Q4 2023 | 2024-01-24 | C+ |
| CSPI | CSP Inc. | Q4 2023 | 2023-12-12 | D |
| ATXS | Astria Therapeutics, Inc. | Q3 2023 | 2023-11-13 | C |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| VCEL | Vericel Corporation | Q3 2023 | 2023-11-08 | A |
| SG | Sweetgreen, Inc. | Q3 2023 | 2023-11-04 | D |
| CHRD | Chord Energy Corporation | Q3 2023 | 2023-11-02 | A |
| PLTR | Palantir Technologies Inc. | Q3 2023 | 2023-11-02 | B |
| REGN | Regeneron Pharmaceuticals, Inc. | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| GSK | GSK plc | Q3 2023 | 2023-11-01 | B |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| MNSO | MINISO Group Holding Limited | Q4 2023 | 2023-08-22 | A |
| PFGC | Performance Food Group Company | Q4 2023 | 2023-08-16 | B+ |
| DNUT | Krispy Kreme, Inc. | Q2 2023 | 2023-08-10 | C |
| RBLX | Roblox Corporation | Q2 2023 | 2023-08-09 | C+ |
| PODD | Insulet Corporation | Q2 2023 | 2023-08-08 | B+ |
| MVST | Microvast Holdings, Inc. | Q2 2023 | 2023-08-07 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| CIVI | Civitas Resources, Inc. | Q2 2023 | 2023-08-03 | B |
| IDT | IDT Corporation | Q3 2023 | 2023-06-05 | C |
| STIM | Neuronetics, Inc. | Q1 2023 | 2023-05-13 | B |
| VECO | Veeco Instruments Inc. | Q1 2023 | 2023-05-08 | B |
| LTH | Life Time Group Holdings, Inc. | Q1 2023 | 2023-04-25 | A |
| SCPH | scPharmaceuticals Inc. | Q4 2022 | 2023-03-22 | C+ |
| COCO | The Vita Coco Company, Inc. | Q4 2022 | 2023-03-08 | B |
| PBPB | Potbelly Corporation | Q4 2022 | 2023-03-02 | A |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| LANC | Lancaster Colony Corporation | Q2 2023 | 2023-02-02 | B+ |
| NVS | Novartis AG | Q4 2022 | 2023-02-01 | B |
| RELL | Richardson Electronics, Ltd. | Q2 2023 | 2023-01-05 | B+ |
| CUTR | Cutera, Inc. | Q3 2022 | 2022-11-05 | C |
| MUR | Murphy Oil Corporation | Q3 2022 | 2022-11-03 | B+ |
| LPX | Louisiana-Pacific Corporation | Q3 2022 | 2022-11-01 | B+ |
| INMD | InMode Ltd. | Q3 2022 | 2022-10-27 | B+ |
| INVZ | Innoviz Technologies Ltd | Q2 2022 | 2022-08-10 | D |
| FLGT | Fulgent Genetics, Inc. | Q2 2022 | 2022-08-04 | C+ |
| GTHX | G1 Therapeutics, Inc. | Q1 2022 | 2022-08-03 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| TMUS | T-Mobile US, Inc. | Q2 2022 | 2022-07-27 | B+ |
| AZO | AutoZone, Inc. | Q3 2022 | 2022-05-24 | B+ |
| AXON | Axon Enterprise, Inc. | Q1 2022 | 2022-05-10 | B+ |
| VEV | Vicinity Motor Corp. | Q4 2021 | 2022-03-30 | D |
| HRTX | Heron Therapeutics, Inc. | Q4 2021 | 2022-02-28 | D |
| INCY | Incyte Corporation | Q4 2021 | 2022-02-08 | C+ |
| TMDX | TransMedics Group, Inc. | Q3 2021 | 2021-11-09 | C+ |
| ATRC | AtriCure, Inc. | Q3 2021 | 2021-11-03 | C |
| SUPN | Supernus Pharmaceuticals, Inc. | Q3 2021 | 2021-11-03 | C+ |
| ZI | ZoomInfo Technologies Inc. | Q3 2021 | 2021-11-01 | A |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| CHWY | Chewy, Inc. | Q2 2021 | 2021-09-01 | B |
| VVV | Valvoline Inc. | Q3 2021 | 2021-08-06 | B+ |
| TIGO | Millicom International Cellular S.A. | Q2 2021 | 2021-07-31 | B+ |
| SAP | SAP SE | Q2 2021 | 2021-07-21 | B+ |
| UPWK | Upwork Inc. | Q3 2018 | 2018-11-11 | B+ |
| MYO | Myomo, Inc. | Q3 2018 | 2018-11-05 | C |
| CFG | Citizens Financial Group, Inc. | Q3 2018 | 2018-10-19 | A |
| UAL | United Airlines Holdings, Inc. | Q3 2018 | 2018-10-17 | B+ |
| INSP | Inspire Medical Systems, Inc. | Q2 2018 | 2018-08-12 | A |
| REI | Ring Energy, Inc. | Q2 2018 | 2018-08-09 | B |
| GAIA | Gaia, Inc. | Q2 2018 | 2018-08-06 | B+ |
| RNG | RingCentral, Inc. | Q2 2018 | 2018-08-06 | A |
| FRPT | Freshpet, Inc. | Q2 2018 | 2018-08-06 | B+ |
| TSLA | Tesla, Inc. | Q2 2018 | 2018-08-02 | B |
| OOMA | Ooma, Inc. | Q1 2019 | 2018-05-22 | A |
| ZG | Zillow Group's | Q1 2018 | 2018-05-08 | C+ |
| QLYS | Qualys, Inc. | Q1 2018 | 2018-05-02 | B+ |
| CPS | Cooper-Standard Holdings Inc. | Q1 2018 | 2018-05-02 | B |
| VRTX | Vertex Pharmaceuticals Incorporated | Q1 2018 | 2018-04-26 | C+ |
| SYK | Stryker Corporation | Q1 2018 | 2018-04-26 | B+ |
| TNC | Tennant Company | Q4 2017 | 2018-02-22 | B |
| TMUS | T-Mobile US, Inc. | Q4 2017 | 2018-02-09 | B+ |
| NICE | NICE Ltd. | Q3 2017 | 2017-11-04 | A |
| SAMG | Silvercrest Asset Management Group Inc. | Q3 2017 | 2017-11-03 | A |
| VC | Visteon Corporation | Q3 2017 | 2017-10-28 | B+ |
| PRO | PROS Holdings, Inc. | Q3 2017 | 2017-10-26 | B+ |
| SRPT | Sarepta Therapeutics, Inc. | Q3 2017 | 2017-10-26 | C+ |
| CAL | Caleres, Inc. | Q2 2017 | 2017-08-29 | B+ |
| LITE | Lumentum Holdings Inc. | Q4 2017 | 2017-08-09 | B+ |
| FRPT | Freshpet, Inc. | Q2 2017 | 2017-08-07 | B+ |
| INTU | Intuit Inc. | Q3 2017 | 2017-05-23 | B+ |
| ADAP | Adaptimmune Therapeutics plc | Q1 2017 | 2017-05-10 | D |
| ISDR | Issuer Direct Corporation | Q1 2017 | 2017-05-06 | C |
| XPO | XPO Logistics, Inc. | Q1 2017 | 2017-05-04 | B |
| SRPT | Sarepta Therapeutics, Inc. | Q1 2017 | 2017-04-28 | D |
| SAH | Sonic Automotive, Inc. | Q1 2017 | 2017-04-26 | C |
| SYK | Stryker Corporation | Q4 2016 | 2017-01-24 | C+ |
| MCS | The Marcus Corporation | Q3 2016 | 2016-10-27 | C+ |
| GSK | GSK plc | Q3 2016 | 2016-10-26 | B |
| VYGR | Voyager Therapeutics, Inc. | Q2 2016 | 2016-08-11 | A |
| SQ | Square's | Q2 2016 | 2016-08-04 | A |
| DGII | Digi International Inc. | Q3 2016 | 2016-07-28 | B |
| PAR | PAR Technology Corporation | Q1 2016 | 2016-05-04 | D |
| PM | Philip Morris International Inc. | Q1 2016 | 2016-04-19 | B+ |
RBLX · Q2 2023 → YESThe task is to evaluate two gates based on the earnings call transcript and return YES only if both are YES, otherwise NO. YES The transcript shows a clear positive current development in advertising, where management's prepared remarks mention live ads, 200 activations, 19% of top 100 with ad units, and some demand exceeding supply. In the Q&A, they add fresh specifics like pricing strategy (gentle now, floating later), new ad unit types, 12% of top 100 using portals, demand in 17-24 female cohort, self-serve options, and brand volume challenges. These details are operational and additive across multiple exchanges, meeting GATE 1 criteria. For GATE 2, advertising is driven by Roblox's own creation and control: 200 activations, portal ad units, self-serve platform, and rollout execution. It's not reliant on external industry tailwinds but on their platform improvements and brand engagement. This satisfies the primary engine condition.
SG · Q3 2023 → YESThe task is to evaluate two gates based on the Sweetgreen earnings call transcript and return YES only if both gates are YES, otherwise NO. YES The transcript shows a clear positive current development in Infinite Kitchen, with management's Q&A responses adding substantial new operational details—such as first-unit performance, customer experience improvements, margin leverage, AUV targeting, retrofit opportunities, and throughput optimizations—that go beyond the prepared remarks' high-level plans. This satisfies Gate 1 criteria for additive, substantive detail across multiple exchanges. For Gate 2, Infinite Kitchen is a proprietary technology the company developed and controls, with momentum driven by its own execution, customer adoption, and operational refinements rather than external tailwinds, making it the primary engine.
ALKT · Q4 2023 → YESThe task is to evaluate two gates based on the earnings call transcript and return YES only if both are YES, otherwise NO. YES The transcript shows a clear positive current development in the bank's market progress and add-on sales momentum, with Q&A providing substantial new operational details like specific backlog numbers, implementation timelines, product adoption rates, and customer-specific challenges that go beyond the prepared remarks. For GATE 2, the primary engine is Alkami's own platform, cloud-native architecture, and execution on replacements of legacy systems, which would largely continue even if external conditions shifted, as the company is actively winning share through its controlled rollout and product improvements.